Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2740 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Santhera launches Friedreich’s Ataxia drug

Catena is claimed to be the first and only approved therapy in Canada to treat this devastating genetic disorder. Santhera estimates that there are a few hundred Friedreich’s

Bayer wins FDA approval for hemophilia drug

This important approval provides these patients with the only factor VIII treatment that the FDA has determined safe and effective for routine prophylaxis – a treatment regimen recommended